These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 33809516)

  • 1. Non-Coding RNAs in Hereditary Kidney Disorders.
    Zhou JX; Li X
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of polycystic kidney disease by non-coding RNAs.
    Ramalingam H; Yheskel M; Patel V
    Cell Signal; 2020 Jul; 71():109548. PubMed ID: 31982550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney disease.
    Pandey P; Qin S; Ho J; Zhou J; Kreidberg JA
    BMC Syst Biol; 2011 Apr; 5():56. PubMed ID: 21518438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA
    Aboudehen K; Farahani S; Kanchwala M; Chan SC; Avdulov S; Mickelson A; Lee D; Gearhart MD; Patel V; Xing C; Igarashi P
    J Biol Chem; 2018 Jun; 293(24):9388-9398. PubMed ID: 29716997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of KLF12 by microRNA-20b and microRNA-106a in cystogenesis.
    Shin Y; Kim DY; Ko JY; Woo YM; Park JH
    FASEB J; 2018 Jul; 32(7):3574-3582. PubMed ID: 29475398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of transcription factor profiles in polycystic kidney disease (PKD): identification and validation of STAT3 and RUNX1 in the injury/repair response and PKD progression.
    Formica C; Malas T; Balog J; Verburg L; 't Hoen PAC; Peters DJM
    J Mol Med (Berl); 2019 Dec; 97(12):1643-1656. PubMed ID: 31773180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs and Long Non-coding RNAs in Genetic Diseases.
    Finotti A; Fabbri E; Lampronti I; Gasparello J; Borgatti M; Gambari R
    Mol Diagn Ther; 2019 Apr; 23(2):155-171. PubMed ID: 30610665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-coding RNAs as potential biomarkers and therapeutic targets in polycystic kidney disease.
    Zheng Q; Reid G; Eccles MR; Stayner C
    Front Physiol; 2022; 13():1006427. PubMed ID: 36203940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal dominant polycystic kidney disease: genetics, mutations and microRNAs.
    Tan YC; Blumenfeld J; Rennert H
    Biochim Biophys Acta; 2011 Oct; 1812(10):1202-12. PubMed ID: 21392578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Trends in ADPKD Research.
    Shin YB; Park JH
    Adv Exp Med Biol; 2016; 933():3-11. PubMed ID: 27730430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic microRNAs in polycystic kidney disease.
    Yheskel M; Patel V
    Curr Opin Nephrol Hypertens; 2017 Jul; 26(4):282-289. PubMed ID: 28399020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riboregulators in kidney development and function.
    Karolina DS; Wintour EM; Bertram J; Jeyaseelan K
    Biochimie; 2010 Mar; 92(3):217-25. PubMed ID: 20045037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic epidemiology of inherited renal disease in Newfoundland.
    Parfrey PS; Davidson WS; Green JS
    Kidney Int; 2002 Jun; 61(6):1925-34. PubMed ID: 12028433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-coding RNAs in kidney injury and repair.
    Liu Z; Wang Y; Shu S; Cai J; Tang C; Dong Z
    Am J Physiol Cell Physiol; 2019 Aug; 317(2):C177-C188. PubMed ID: 30969781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression.
    Streets AJ; Magayr TA; Huang L; Vergoz L; Rossetti S; Simms RJ; Harris PC; Peters DJ; Ong AC
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F577-F588. PubMed ID: 28077374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary Renal Diseases.
    Mehta L; Jim B
    Semin Nephrol; 2017 Jul; 37(4):354-361. PubMed ID: 28711074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics and cell cycle regulation in cystogenesis.
    Li X
    Cell Signal; 2020 Apr; 68():109509. PubMed ID: 31874209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiny Non-coding RNAs in Body Fluids, Possible Biomarkers for Autosomal Dominant Polycystic Kidney Disease.
    Ghasemi Y; Tayebi-Khosroshahi H; Abedi B; Rahmati-Yamchi M; Alizadeh E
    Iran J Kidney Dis; 2019 May; 13(3):151-164. PubMed ID: 31209188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autosomal dominant polycystic kidney disease: Disrupted pathways and potential therapeutic interventions.
    Malekshahabi T; Khoshdel Rad N; Serra AL; Moghadasali R
    J Cell Physiol; 2019 Aug; 234(8):12451-12470. PubMed ID: 30644092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MicroRNAs and kidneys].
    Stříteská J; Nekvindová J; Cerný V; Palička V
    Cas Lek Cesk; 2014; 153(4):187-92. PubMed ID: 25199544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.